Permanent radioactive seed implantation in the treatment of prostate cancer.
Prostate brachytherapy has come a long way in the last 15 years, from an open free-hand technique with which seed placement was often inaccurate to the highly technical and accurate procedure of today. It has become a viable treatment option for low-risk patients along with EBRT and prostatectomy. Its most promising use may be in combination with hormonal therapy and EBRT in moderate- to high-risk patients, for whom it may offer improved outcomes over standard single-modality therapies.
Stock
R G
RG
Department of Radiation Oncology, Mount Sinai Medical Center, New York, New York, USA.
Stone
N N
NN
D001918:Brachytherapy / Q000009:adverse effects; D003131:Combined Modality Therapy / Q000009:adverse effects; D006728:Hormones / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*
D006728:Hormones